Mood, anxiety and sense of humor in head and neck cancer patients in relation to disease stage, prognosis and quality of life

被引:46
作者
Aarstad, HJ [1 ]
Aarstad, AKH [1 ]
Heimdal, JH [1 ]
Olofsson, J [1 ]
机构
[1] Univ Bergen, Haukeland Univ Hosp, Dept Otolaryngol Head & Neck Surg, NO-5021 Bergen, Norway
关键词
anxiety; depression; neoplasms; prognosis; quality of life; sense of humor;
D O I
10.1080/00016480510027547
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Conclusion. At diagnosis, control patients had the lowest depression levels and anxiety scores, followed by those with limited HNSCC disease and these with extended HNSCC disease. Anxiety and depression levels at diagnosis predicted prognosis via an association with extent of disease. Sense of humor, but not anxiety or depression level, predicted lower QoL and depression levels at follow-up. Objective. To study the association between anxiety score, depression level at sense of humor at diagnosis in head and neck squamous cell carcinoma ( HNSCC) patients versus TNM stage, prognosis and depression level/quality of life (QOL) 6 years following diagnosis. A control group of patients with benign HN disease was also included. Material and methods. Male patients with newly diagnosed HNSCC ( n = 78) or benign HN ( n = 61) disease completed the following questionnaires: the Beck Depression Inventory, the Spielberger Trait Anxiety Inventory ( state) and the Svebak humor questionnaire. Patients with cachexia or those aged > 80 years were excluded. In the HNSCC patients, TNM stage, prognosis and QOL/depression level ( n = 27) were determined following successful therapy. Results. HNSCC patients reported high anxiety scores and lower depression levels than control patients, although there was overlap between the groups. N stage was associated with high anxiety scores and depression levels, whereas T stage was only associated with depression levels. Both anxiety scores and depression levels at diagnosis predicted prognosis through an association with TNM stage. Sense of humor, but not depression levels or anxiety scores, at diagnosis predicted QoL and depression levels at follow-up.
引用
收藏
页码:557 / 565
页数:9
相关论文
共 29 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   The personality and quality of life in HNSCC patients following treatment [J].
Aarstad, HJ ;
Aarstad, AKH ;
Birkhaug, EJ ;
Bru, E ;
Olofsson, J .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (13) :1852-1860
[3]   Personality traits in head and neck squamous cell carcinoma patients in relation to the disease state, disease extent and prognosis [J].
Aarstad, HJ ;
Heimdal, JH ;
Aarstad, AKH ;
Olofsson, J .
ACTA OTO-LARYNGOLOGICA, 2002, 122 (08) :892-899
[4]  
[Anonymous], 1964, MANUAL EYSENCK PERSO, DOI DOI 10.1007/SPRINGERREFERENCE_184643
[5]  
Beck A.T., 1967, DEPRESSION
[6]   Relation between mood, social support and the quality of life in patients with laryngectomies [J].
Birkhaug, EJ ;
Aarstad, HJ ;
Aarstad, AKH ;
Olofsson, J .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2002, 259 (04) :197-204
[7]   Quality of life in head and neck cancer patients:: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire -: H&N35 [J].
Bjordal, K ;
Hammerlid, E ;
Ahlner-Elmqvist, M ;
de Graeff, A ;
Boysen, M ;
Evensen, JF ;
Biörklund, A ;
de Leeuw, JRJ ;
Fayers, PM ;
Jannert, M ;
Westin, T ;
Kaasa, S .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :1008-1019
[8]   DEVELOPMENT OF A EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) QUESTIONNAIRE MODULE TO BE USED IN QUALITY-OF-LIFE ASSESSMENTS IN HEAD AND NECK-CANCER PATIENTS [J].
BJORDAL, K ;
AHLNERELMQVIST, M ;
TOLLESSON, E ;
JENSEN, AB ;
RAZAVI, D ;
MAHER, EJ ;
KAASA, S .
ACTA ONCOLOGICA, 1994, 33 (08) :879-885
[9]   A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients [J].
Bjordal, K ;
de Graeff, A ;
Fayers, PM ;
Hammerlid, E ;
van Pottelsberghe, C ;
Curran, D ;
Ahlner-Elmqvist, M ;
Maher, EJ ;
Meyza, JW ;
Brédart, A ;
Söderholm, AL ;
Arraras, JJ ;
Feine, JS ;
Abendstein, H ;
Morton, RP ;
Pignon, T ;
Huguenin, P ;
Bottomly, A ;
Kaasa, S .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (14) :1796-1807
[10]  
DALTON SO, 2000, EUR J CANCER, V38, P1313